Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic and Hormonal Effects of 5:2 Intermittent Fasting in Patients With Type 2 Diabetes and Subjects With Adiposity

NCT02450097 is registered in ClinicalTrials.gov with Karolinska University Hospital as lead sponsor.

NCT NCT02450097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02450097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic and Hormonal Effects of 5:2 Intermittent Fasting in Patients With Type 2 Diabetes and Subjects With Adiposity
Lead sponsor
Karolinska University Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2013
Completion date
December 31, 2017
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type 2, obesity